RE:Which is it?I don't understand it either. I thought the Shorting was due to financial issues, perceived as not having enough cash to get thru to the revenue point for pg. But since the latest financing we have done nothing but continue the decrease in stock price. What is it going to take to turn this around? Do the long term guys here think that there could be something in the CC this week that could provide a catalyst for a rally? Or will the Earnings release take us below $2 again. Trying to stay positive here, but getting discouraged by the down trend. We really need to see a regional / worldwide deal with $50-$100+ million upfront cash and milestones. Something to prove that the majors think the science works, and that they are not considering other competition that might be lurking?
1wascallywabbit wrote: Was financing the issue or not? If so, it must still be an issue as $25mil is deemed not enough?
Maybe financing was never the issue, so in that case, what is it? Does the market collectively doubt that they can get anything past the FDA? I thought they would have something to drive this higher and make the Shorts nervous before the Conference Call at month end? Time is getting short - time to "deliver".